Structure and function of mGluR3 interactions with beta-arrestins and the membrane.
mGluR3 与 β-arrestins 和膜相互作用的结构和功能。
基本信息
- 批准号:10536255
- 负责人:
- 金额:$ 6.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAgonistAlanineAlzheimer&aposs DiseaseAnxietyArrestinsAwardBindingBiochemicalBiological AssayBiophysicsC-terminalCell physiologyCellsCellular AssayClathrinCollaborationsComplexCouplingCryoelectron MicroscopyDataDevelopmentDiseaseEnvironmentEventFaceFamilyFluorescenceFoundationsG Protein-Coupled Receptor SignalingG protein coupled receptor kinaseG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGlutamatesGoalsHeterotrimeric GTP-Binding ProteinsIn VitroLeadLengthLibrariesMeasurementMeasuresMediatingMembraneMembrane LipidsMembrane ProteinsMental DepressionMental disordersMentorsMetabotropic Glutamate ReceptorsMethodsMolecularMolecular ConformationMonomeric GTP-Binding ProteinsMutationNMR SpectroscopyNeuronsNeurotransmittersNucleotidesOutcomePathway interactionsPatternPhospholipidsPhosphorylationPhotobleachingPopulationProcessProtein IsoformsProteinsProtomerPublicationsRegulationReportingResearchResearch DesignResearch PersonnelResolutionSchizophreniaSerineSerine/Threonine PhosphorylationSignal PathwaySignal TransductionSiteStimulusStructureSynapsesSystemTechniquesTertiary Protein StructureThermodynamicsThreonineTrainingTransmembrane DomainVariantWorkarrestin 1autism spectrum disorderbasebeta-arrestinbiophysical techniquescareercellular imagingdesensitizationdimerexperienceextracellularhigh throughput screeningimprovedin vivo Modelinnovationmedical schoolsmeetingsnervous system disordernovelprogramsprotein functionreceptorreceptor functionreceptor internalizationrecruitresponsesingle moleculestoichiometry
项目摘要
PROJECT SUMMARY
This proposal contains a comprehensive program to support a transition toward an independent research career
focused on understanding how membrane protein function is modulated by interactions with other proteins and
phospholipid membranes, and how this modulation impacts cellular processes and is altered in disease-states.
This application describes an innovative and ambitious proposal directly tied to my career and training goals.
Background: G protein-coupled receptors (GPCR) are membrane proteins that sense extracelluar stimuli and
initiate intracellular signaling pathways through interactions with cytosolic G proteins. Classically, GPCRs are
thought to undergo a multi-step inactivation and desensitization process via interactions with β-arrestins following
hyper-phosphorylation of the intrinsically-disordered GPCR C-terminal domain (CTD). β-arrestins can also
initiate distinct signaling cascades in addition to desensitizing and internalizing GPCRs, though the molecular
determinants for each pathway are not well understood. This system is further complicated by the presence of
two β-arrestin isoforms which are thought to prefer different GPCR CTD phosphorylation patterns and may
initiate different cellular pathways. Metabotropic glutamate receptors (mGluR) are dimeric, neuronal GPCRs that
are responsible for sensing main excitatory neurotransmitter glutamate both pre- and post-synaptically. Recently
a single isoform, mGluR3, was identified to undergo robust β-arrestin-mediated internalization and the β-arrestin-
binding region of the CTD was identified. This was the first reported interaction between a dimeric GPCR and β-
arrestins, leading to novel questions about complex stoichiometry and structure. This mGluR3-β-arrestin
interaction is further complicated by preliminary data indicating that the β-arrestin binding region of the mGluR3
CTD also interacts with the phospholipid membrane. Specific Aims and Research Design: The proposed study
investigates the interactions between mGluR3 and both β-arrestins and the membrane using a combination of
1) single-molecule and ensemble fluorescence-based binding methods to investigate the determinants of the
formation of mGluR3-β-arrestin complexes, and 2) cryo-electron microscopy and nuclear magnetic resonance
spectroscopy to assess the structural features of interactions between mGluR3, β-arrestins, and the membrane.
My in vitro and structural findings will be validated using cellular assays and imaging. Findings will inform a
K99/R00 proposal aimed to apply the approaches and findings from this F32 research program broadly to other
GPCRs and to pursue the functional consequences of GPCR-β-arrestin coupling in in vivo models. Training
and Mentoring: Training goals are supported by 1) a team of co-sponsors Drs. Levitz and Eliezer and a close
collaborator (Dr. Meyerson) with expertise in biophysical and biochemical research, 2) a rich institutional
environment at Weill Cornell Medical College, and 3) scientific meetings, seminars, and planned publications.
Impact: The experience gained during this award will serve at the foundation for my independent career as a
protein biophysics researcher and for the development of a novel program of membrane protein research.
项目摘要
该提案包含一个全面的计划,以支持向独立研究职业的过渡
专注于了解膜蛋白功能如何通过与其他蛋白质的相互作用和
磷脂膜,以及该调节如何影响细胞过程并在疾病范围内改变。
该应用程序描述了与我的职业和培训目标直接相关的创新和雄心勃勃的提议。
背景:G蛋白偶联受体(GPCR)是膜蛋白,感知外部刺激和
通过与胞质G蛋白相互作用来引发细胞内信号通路。经典,GPCR是
被认为是通过与β-arrestin的相互作用的多步灭活和脱敏过程
内部排序的GPCR C末端结构域(CTD)的高磷酸化。 β-arrestin也可以
除了分子外,还可以启动不同的信号级联反应和内化GPCR
每种途径的决定因素尚不清楚。由于存在,该系统更加复杂
两种β-甲蛋白同工型被认为偏爱不同的GPCR CTD磷酸化模式,并且可能
启动不同的细胞途径。代谢性谷氨酸受体(MGLUR)是二聚体的神经元GPCR,
负责感测前后的主要兴奋性神经递质谷氨酸。最近
鉴定出一种单一的同工型MGLUR3可以进行鲁棒的β-arrestin介导的内在化和β-arrestin-
确定了CTD的结合区域。这是二聚体GPCR和β-的第一次相互作用
逮捕蛋白,导致有关复杂化学计量和结构的新问题。这种MGLUR3-β-arrestin
初步数据表明MGLUR3的β-甲素结合区域进一步复杂化。
CTD还与磷脂膜相互作用。具体目的和研究设计:拟议的研究
通过组合使用
1)基于单分子和集合荧光的结合方法研究了
MGLUR3-β-arrestin复合物的形成,以及2)冷冻电子显微镜和核磁共振
光谱法评估MGLUR3,β-arrestin和膜之间相互作用的结构特征。
我的体外和结构发现将通过细胞测定和成像进行验证。调查结果将告知
拟议的K99/R00旨在将此F32研究计划的方法和发现广泛应用于其他
GPCR并追求体内模型中GPCR-β-arrestin耦合的功能后果。训练
和指导:培训目标得到1)一组共同赞助商DRS的支持。莱维兹和埃利泽以及关闭
合作者(Meyerson博士)具有生物物理和生化研究专业知识,2)丰富的机构
威尔·康奈尔医学院(Weill Cornell Medical College)的环境,以及3)科学会议,半人选和计划出版物。
影响:该奖项中获得的经验将在我的独立职业基金会上作为一个
蛋白质生物物理学研究人员以及为膜蛋白研究的新计划的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dagan Marx其他文献
Dagan Marx的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dagan Marx', 18)}}的其他基金
Structure and function of mGluR3 interactions with beta-arrestins and the membrane.
mGluR3 与 β-arrestins 和膜相互作用的结构和功能。
- 批准号:
10704588 - 财政年份:2022
- 资助金额:
$ 6.72万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 6.72万 - 项目类别:
Development of first-in-class antagonists of the retinoid pathway as novel oral therapies for Type 2 Diabetes
开发类视黄醇途径的一流拮抗剂作为 2 型糖尿病的新型口服疗法
- 批准号:
10699637 - 财政年份:2023
- 资助金额:
$ 6.72万 - 项目类别:
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 6.72万 - 项目类别:
Sigma 2 Receptor (TMEM97): Investigating the Peripheral Role of this Novel Therapeutic Target for Pain
Sigma 2 受体 (TMEM97):研究这种新型疼痛治疗靶点的外周作用
- 批准号:
10607436 - 财政年份:2023
- 资助金额:
$ 6.72万 - 项目类别: